AcclaimIP vs IPRally

AcclaimIP helps corporate IP teams, law firms, and other IP professionals search patent information, analyze portfolios, and prepare reports for legal, strategic, and business decisions. It covers more than 175 million patent documents from 106 patenting jurisdictions, with an average of over 170,000 additions each week. Teams can use it for prior-art searches, technology landscape reviews, competitor monitoring, and contextual analysis of search results. Portfolio tools support assessment of patent strength, coverage, and competitive position for filing, prosecution, portfolio review, licensing, and enforcement. Visual outputs can be shared with stakeholders. AcclaimIP runs in a standard web browser, within a single browser tab, and is available as a standalone subscription or integrated with Anaqua platforms including AQX and PATTSY WAVE. Searcher, Practitioner, and Analyst access levels offer different capabilities; Practitioner adds USPTO file-wrapper access, while Analyst adds analytics and private-data tools. Custom fields require a paid add-on, and API use requires an additional license and customer programming work. Pricing is on request; licensing is annual, prepaid, and per seat.

IPRally is an AI platform for patent search, intelligence, and drafting across the patent lifecycle. It supports prior-art, invalidity, and freedom-to-operate searches, plus search agents and claim charting. Intelligence functions cover classification, monitoring, patent landscapes, and macro analysis. Search results link to the source patent passage or figure for evidence review. Every plan includes a continuously updated full-text corpus of more than 130 million patents across 58 jurisdictions. Access can be through the web product, API, MCP connections, or secure on-premise deployment. MCP connections are listed for Claude, ChatGPT, Gemini, Copilot, and Cursor. IPRally states that it is ISO 27001 and SOC 2 Type II certified, encrypts data in transit and at rest, and does not retain searches or drafts. Plans target individual users, teams, law firms, and patent or trademark offices. Pricing is on request. The pricing note mentions a 3-day trial, while formal evaluation trials are offered at the company’s discretion and duration is not otherwise specified.